[The clinical use of an association of hydrochlorothiazide and triamterene in nephrotic syndromes].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy; D002648:Child; D003928:Diabetic Nephropathies / Q000188:drug therapy; D004231:Diuresis / Q000187:drug effects; D004573:Electrolytes / Q000378:metabolism; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D014223:Triamterene / Q000627:therapeutic use*
D004573:Electrolytes; D006852:Hydrochlorothiazide; D014223:Triamterene
L'impiego clinico di una associazoine di idroclorotiazide e trimterene nelle sindromi nefrosiche.